A British Olympic athlete has cautioned that the increase in weight loss Jabs might lead to a resurgence of scurvy epidemics.
The former speed skater Sarah Lindsay, who is 44 years old, thinks that medications such as Ozempic and Mounjaro might lead users to become malnourished and lacking in vitamins.
The well-known celebrity personal trainer, who counts among his clients Piers Morgan , Ellie Goulding , Matt Healy and Christine Lampard has disclosed that certain individuals misuse medications.
She worries that the growing popularity of weight-loss injections might result in a resurgence of scurvy. This condition arises due to insufficient Vitamin C intake from fruits and veggies, which is crucial for maintaining the health of your skin, blood vessels, and connective tissues.
Over two million seafarers, who primarily subsisted on preserved food with scarce access to fruits and veggies, perished from this ailment during the period spanning the 16th to the 18th century.
Sarah acknowledged that individuals with specific medical issues might gain advantages from using GLP-1 medications, also referred to as "jabs."
However, she told the Sun :The extent of such abuse nowadays is widespread — individuals who are already slim desiring to be even more slender.
I've had clients seek physical therapy consultations when they're desperately trying to climb out of the rut they’re in: feeling weakened, exhausted, suffering from poor digestion, and experiencing significant hair loss.



Her primary two worries regarding the injections are 'muscle atrophy' and 'the long-term impacts of nutrient deficiency'.
She cautioned that the vaccines might lead to people feeling unwell or potentially trigger a resurgence of deficiencies such as scurvy.
Weight loss medications like Ozempic, Wegovy, and Mounjaro are all injectable GLP-1 receptor agonists, and they function by mimicking a hormone produced in the body that manages how quickly food is processed within the digestive tract - decelerating this process. This diminishes hunger and aids individuals in consuming smaller portions.
Earlier this week, Dr Ben Bickman, a scientist and professor at Brigham Young University in Utah, warned of three harmful consequences of these medications that he believes many are unaware of.
First off, he told the Mail he is concerned about pervasive weakness resulting from severe loss of muscle and bone density associated with these medications.
In a 68-week clinical study of semaglutide—the key component in both Ozempic and Wegovy—participants shed an average of 23 pounds of body weight. Additionally, they experienced various other effects. noticed a reduction of 15 pounds in lean muscle mass.
This point is considerably more subjective, but Dr Bickman thinks Ozempic might cause individuals to become 'mentally vulnerable'.
He highlights anecdotal evidence from patients who say that Ozempic not only blunted not only their desire for nourishment but also for various enjoyments in life like intimacy, spirits, caffeine, and more. .


Up next, Dr. Bickman suggests that over time, weight-loss medications might end up making individuals more overweight than when they started.
He explains how individuals may eventually gain back weight after using Ozempic for some time, stating: "Ozempic effectively curbs hunger... Nonetheless, its effectiveness wanes over time."
Around two years into usage, individuals notice that their desire for sweets returns to a typical level.
'Notably, this is also around the time when numerous individuals choose to discontinue the medication, with approximately 70 percent ceasing use after two years.'
Even though he has reservations about the side effects of Ozempic and similar weight-loss medications, Dr Bickman emphasizes that he isn’t opposed to their use; rather, his main worry lies with how they are prescribed.
People who have type 2 diabetes use Ozempic weekly as an adult to reduce their blood glucose levels, typically starting with a dosage of 0.25 mg.
This reduced dosage enables the body to adjust to the medication.
In Week Five, physicians generally boost the dosage to 0.5 mg once per week provided the patient handles the medication well.
Patients focusing on weight loss usually adhere to the standard dosage regimen, though their dose could be raised up to 2 mg per week.
Read more